Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi T May

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
European Heart Journal|July 2, 2014
HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators CollaborativeSeth S Martin, Arif A Khokhar, Heidi T May, et al.
Journal of Cardiovascular Electrophysiology|May 29, 2009
Warfarin is not needed in low-risk patients following atrial fibrillation ablation proceduresT Jared Bunch, Brian G Crandall, J Peter Weiss, et al.
Pacing and Clinical Electrophysiology : PACE|September 8, 2011
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocksT Jared Bunch, Srijoy Mahapatra, David Murdock, et al.
European Journal of Heart Failure|August 14, 2010
The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpointsBenjamin D Horne, Heidi T May, Abdallah G Kfoury, et al.
American Heart Journal|January 28, 2020
Feasibility of combining serial smartphone single-lead electrocardiograms for the diagnosis of ST-elevation myocardial infarctionJoseph Boone Muhlestein, Jeffrey L Anderson, Charles F Bethea, et al.
American Heart Journal|August 20, 2020
Smartphone 12-lead ECG-Exciting but must be handled with careJoseph Brent Muhlestein, Joseph Boone Muhlestein, Jeffrey L Anderson, et al.
American Heart Journal|September 19, 2021
Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery diseaseTyson S Burnham, Heidi T May, Tami L Bair, et al.
Plos One|July 23, 2013
Repeated measurement of the intermountain risk score enhances prognostication for mortalityBenjamin D Horne, Donald L Lappé, Joseph B Muhlestein, et al.
Frontiers in Cardiovascular Medicine|September 8, 2023
Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular eventsViet T Le, Stacey Knight, Jeramie D Watrous, et al.
Heart Rhythm|August 12, 2014
Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementiaVictoria Jacobs, Scott C Woller, Scott Stevens, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
European Heart Journal|July 2, 2014
HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators CollaborativeSeth S Martin, Arif A Khokhar, Heidi T May, et al.
Journal of Cardiovascular Electrophysiology|May 29, 2009
Warfarin is not needed in low-risk patients following atrial fibrillation ablation proceduresT Jared Bunch, Brian G Crandall, J Peter Weiss, et al.
Pacing and Clinical Electrophysiology : PACE|September 8, 2011
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocksT Jared Bunch, Srijoy Mahapatra, David Murdock, et al.
European Journal of Heart Failure|August 14, 2010
The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpointsBenjamin D Horne, Heidi T May, Abdallah G Kfoury, et al.
American Heart Journal|January 28, 2020
Feasibility of combining serial smartphone single-lead electrocardiograms for the diagnosis of ST-elevation myocardial infarctionJoseph Boone Muhlestein, Jeffrey L Anderson, Charles F Bethea, et al.
American Heart Journal|August 20, 2020
Smartphone 12-lead ECG-Exciting but must be handled with careJoseph Brent Muhlestein, Joseph Boone Muhlestein, Jeffrey L Anderson, et al.
American Heart Journal|September 19, 2021
Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery diseaseTyson S Burnham, Heidi T May, Tami L Bair, et al.
Plos One|July 23, 2013
Repeated measurement of the intermountain risk score enhances prognostication for mortalityBenjamin D Horne, Donald L Lappé, Joseph B Muhlestein, et al.
Frontiers in Cardiovascular Medicine|September 8, 2023
Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular eventsViet T Le, Stacey Knight, Jeramie D Watrous, et al.
Heart Rhythm|August 12, 2014
Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementiaVictoria Jacobs, Scott C Woller, Scott Stevens, et al.
Pageof 16